RA Capital Management - PHATHOM PHARMACEUTICALS INC ownership

PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
RA Capital Management ownership history of PHATHOM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$61,272,000
-38.7%
3,115,0080.0%1.08%
-22.1%
Q3 2021$99,992,000
-5.2%
3,115,0080.0%1.39%
-18.1%
Q2 2021$105,443,000
-9.9%
3,115,0080.0%1.69%
-4.1%
Q1 2021$117,000,000
-7.9%
3,115,008
-18.6%
1.76%
-0.7%
Q4 2020$127,067,000
-9.4%
3,825,0080.0%1.78%
-30.8%
Q3 2020$140,263,000
+11.4%
3,825,0080.0%2.57%
+4.6%
Q2 2020$125,881,000
+31.5%
3,825,008
+3.2%
2.45%
-18.9%
Q1 2020$95,725,000
-15.7%
3,707,408
+1.7%
3.02%
-12.2%
Q4 2019$113,562,0003,646,8083.44%
Other shareholders
PHATHOM PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 3,760,869$39,000,21212.45%
Frazier Life Sciences Management, L.P. 10,109,279$104,833,2236.96%
Decheng Capital Management III (Cayman), LLC 850,000$8,814,5002.94%
Carlyle Group Inc. 3,496,808$36,191,9631.57%
Ghost Tree Capital, LLC 395,000$4,096,1501.35%
Newtyn Management, LLC 500,000$5,185,0001.28%
Altium Capital Management LP 220,000$2,281,4001.19%
StepStone Group LP 422,085$4,377,0210.98%
MPM BioImpact LLC 347,332$3,601,8330.96%
NEA Management Company, LLC 1,276,595$12,238,2900.94%
View complete list of PHATHOM PHARMACEUTICALS INC shareholders